DTC Limits Best Countered By Free Speech, Not Public Health, Arguments
Executive Summary
Limits on direct-to-consumer advertising which have been proposed in pending drug safety legislation may best be defeated by constitutional, rather than public health, arguments, Jim Davidson, president of the public policy advisory firm Davidson & Company, said
You may also be interested in...
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
The revised language on direct-to-consumer advertising in the FDA safety bills pending in Congress no longer allows the agency to ban ads, but creates a number of new disclosure requirements for the spots
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
The revised language on direct-to-consumer advertising in the FDA safety bills pending in Congress no longer allows the agency to ban ads, but creates a number of new disclosure requirements for the spots